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Abstract: Type 2 diabetes mellitus (T2DM) is a metabolic disorder characterized by unpaired blood
glycaemia maintenance. T2DM can be treated by inhibiting carbohydrate hydrolyzing enzymes
(α-amylases and α-glucosidases) to decrease postprandial hyperglycemia. Acarbose and voglibose
are inhibitors used in clinical practice. However, these drugs are associated with unpleasant
gastrointestinal side effects. This study explores new α-amylase inhibitors deriving from plant volatile
specialized metabolites. Sixty-two essential oils (EOs) from different plant species and botanical
families were subjected to α-amylase in vitro enzymatic assay and chemically characterized using gas
chromatography coupled to mass spectrometry. Several EOs were found to be potential α-amylase
inhibitors, and Eucalyptus radiata, Laurus nobilis, and Myristica fragrans EOs displayed inhibitory
capacities comparable to that of the positive control (i.e., acarbose). A bio-guided fractionation
approach was adopted to isolate and identify the active fractions/compounds of Eucalyptus radiata and
Myristica fragrans EOs. The bio-guided fractionation revealed that EOs α-amylase inhibitory activity is
often the result of antagonist, additive, or synergistic interactions among their bioactive constituents
and led to the identification of 1,8-cineole, 4-terpineol, α-terpineol, α-pinene, andβ-pinene as bioactive
compounds, also confirmed when they were tested singularly. These results demonstrate that EO oils
are a promising source of potential α-amylase inhibitors.
Keywords: essential oil; α-amylase inhibition; bio-guided fractionation; Myristica fragrans; Eucalyptus
radiata
1. Introduction
The term "diabetes mellitus" groups together a series of metabolic disorders characterized by
hyperglycemia that is caused by the impairment of insulin secretion, action, or both. If not treated,
chronic hyperglycemia, in association with diabetes, leads to long-term damage, dysfunction and organ
failure especially in the eyes, kidneys, heart, nerves, and blood vessels [1]. Diabetes is classified into
two broad etiopathogenetic categories: type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus
(T2DM). T1DM is related to hyperglycemia caused by an absolute deficiency of insulin secretion
and requires exogenous insulin administration if a patient is to survive. T2DM affects 90 to 95% of
diabetic patients with impaired glucose tolerance that is related to diminished tissue response to
insulin and is often associated with relative insulin deficiency. A common therapeutic approach for
TD2M, especially for patients with unpaired post-prandial blood glucose excursion, is to inhibit the
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carbohydrate digestive enzymes (α-amylases and α-glucosidases) in order to delay glucose absorption
and mitigate the post prandial increase in blood glucose [1]. α-Amylases (salivary and pancreatic
α-amylases) are involved in the early stage of complex carbohydrate digestion, as they catalyze the
hydrolysis of 1,4-α-glucosidic bonds in glucose units of long chain carbohydrates (i.e., amylose and
amylopectin) forming maltose, maltotriose, and α-limit dextrin residues, which are then hydrolyzed
into D-glucose monomers by α-glucosidases. Commonly prescribed α-glucosidase and α-amylase
inhibitors (e.g., acarbose) are only partially effective at decreasing hyperglycemia [2], and present
unpleasant gastrointestinal sides effects (i.e., meteorism, flatulence, and diarrhea) [3,4].
Medicinal plants have proven to be potentially promising in the treatment of T2DM. Hydroalcoholic
and aqueous extracts that are rich in phenolic compounds, such as anthocyanins from Ipomoea batatas
(L.) Poir. (Convolvulaceae) and Pharbitis nil (L.) Choisy (Convolvulaceae), and polyphenols from
Pinus pinaster Aiton (Pinaceae), have effective inhibitory activity against intestinal α-glucosidase and
α-amylases from human salivary glands [5–7].
Relatively less attention has been paid to volatile compounds (e.g., terpenoids) and to essential
oils (EOs). They are complex mixtures of volatiles that are either obtained by steam distillation, dry
distillation, or by mechanical means from a single plant species. Terpenoids are the most important
group of specialized metabolites in EOs, and include, in particular, hemiterpenoids (C5), monoterpenoids
(C10), and sesquiterpenoids (C15), whose volatility is compatible with the steam distillation process [8].
In addition to their use in the flavor and fragrance fields, EOs and their components are known for
their wide range of biological activities. Specific EOs/EO components have proven to be effective for
use as adjuvants in the treatment of a broad range of pathological conditions, including functional
dyspnea (Mentha x piperita and Carum carvi EOs) [9], irritable bowel syndrome (Mentha x piperita EO) [10],
respiratory disorders (i.e., menthol and 1,8-cineole) [10–12], gastroesophageal reflux (i.e., limonene) [13],
and the dissolution of hepatic and renal stones (i.e., Rowatinex®, a commercial mixture of α-pinene,
β-pinene, camphene, borneol, anethol, fenchone, and 1,8-cineole) [14,15]. To the best of the authors
knowledge, very few studies have been performed on the effect of EOs on T2DM, and those reported
in the literature mainly focus on the inhibitory activity of individual EO components rather than on an
EO as a whole [16–18].
This study deals with the preliminary screening of 62 hydrodistilled EOs from different botanical
families and species, in order to evaluate their potential hypoglycemic activity (i.e., α-amylase inhibition
activity). Bio-guided fractionation, based on an in vitro α-amylase inhibition assay, was also performed
to isolate the bioactive fractions and/or to identify the EO components with the most significant activity.
Gas chromatography coupled to mass spectrometry (GC-MS) was used to identify the compounds
that are characteristic of both the EOs and the isolated fractions, and that are responsible for their
α-amylase inhibition activity.
2. Results and Discussion
Table 1 reports a list of the 62 EOs screened in this study. They belong to different botanical
families (i.e., Annonaceae, Apiaceae, Compositae, Cupressaceae, Ericaceae, Geraniaceae, Lamiaceae,
Lauraceae, Myristicaceae, Myrtaceae, Oleaceae, Pinaceae, Piperaceae, Poaceae, Rosaceae, Rutaceae,
Santalaceae, Verbenaceae, Zingiberaceae), as described in Figure 1.
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Table 1. List of the investigated essential oils (EOs), the part of the plant used to obtain them,
botanical and common names, and percentage of α-amylase inhibition activity measured by absorbance
differences (Method A).
Species Family Common Name Plant Part % InhibitionActivity
Standard
Deviation
Artemisia vulgaris L. Compositae Mugwort Leaf/Flower 48 3
Cananga odorata (Lam.)
Hook.f. and Thomson Annonaceae Ylang-ylang Flower no activity -
Carum carvi L. Apiaceae Caraway Seed 17 2
Cedrus atlantica (Endl.)
Manetti ex Carrière Pinaceae Cedar wood Wood no activity -
Chrysopogon zizanioides
(L.) Roberty Poaceae Vetiver Root no activity -
Cinnamomum zeylanicum
Nees Lauraceae Cinnamon leaf Leaf no activity -
Cinnamomum zeylanicum
Nees Lauraceae Cinnamon bark Bark no activity -
Cinnamomum camphora
(L.) J.Presl Lauraceae Camphor Wood 20 2
Cinnamomum cassia (L.)
J.Presl Lauraceae Cinnamon bark Bark no activity -
Citrus × aurantium L. Rutaceae Bitter orange Fruit peel 23 5
Citrus × aurantium L. Rutaceae Neroli Flower 20 1
Citrus × aurantium L. Rutaceae Petitgrain Leaf 4 1
Citrus bergamia Risso
et Poiteau Rutaceae Bergamot Fruit peel 16 3
Citrus limon (L.) Osbeck Rutaceae Lemon Fruit peel 15 2
Citrus medica L. Rutaceae Finger citron Fruit peel 14 4
Citrus nobilis Lour. Rutaceae Mandarin Fruit peel no activity -
Citrus paradisi Macfad. Rutaceae Grapefruit Fruit peel no activity -
Citrus sinensis (L.)




Myrtaceae Eucalyptus.lemon-scented Leaf 44 5
Cupressus sempervirens L. Cupressaceae Cypress Leaf/Twig 17 1
Cymbopogon martini
(Roxb.) W.Watson. Poaceae Palmarosa Leaf no activity -
Cymbopogon nardus (L.)
Rendle Poaceae Citronella Ceylon Leaf 22 2
Cymbopogon schoenanthus
(L.) Spreng. Poaceae Lemongrass Leaf 7 2
Elettaria cardamomum (L.)
Maton Zingiberaceae Cardamom Seed 10 3
Eucalyptus globulus
Labill. Myrtaceae Eucalyptus Leaf 34 3
Eucalyptus radiata
A.Cunn. ex DC. Myrtaceae Leaf 65 4
Foeniculum vulgare Mill. Apiaceae Fennel Fruit no activity -
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Table 1. Cont.
Species Family Common Name Plant Part % InhibitionActivity
Standard
Deviation
Gaultheria procumbens L. Ericaceae Wintergreen Leaf no activity -
Hyssopus officinalis L. Lamiaceae Hyssop Leaf 18 1
Jasminum officinale L. Oleaceae Jasmine Flowers no activity -
Juniperus communis L. Cupressaceae Juniper berry Fruit 5 2
Juniperus virginiana L. Cupressaceae Cedarwood Wood 15 2
Laurus nobilis L. Lauraceae Laurel Leaf 50 4
Lavandula angustifolia
Mill. × L. latifolia Medik. Lamiaceae Lavandin Leaf 6 3
Lavandula angustifolia
Mill. Lamiaceae Lavender Leaf 5 2




Myrtaceae Tea tree Leaf 14 2
Melaleuca viridiflora Sol.
ex Gaertn. Myrtaceae Niaouli Leaf 28 4
Melissa officinalis L. Lamiaceae Lemon balm Leaf no activity -
Mentha × piperita L. Lamiaceae Peppermint Leaf 33 3
Mentha × piperita L. Lamiaceae Peppermint Leaf/twig 40 5
Mentha arvensis L. Lamiaceae Mint Leaf 39 6
Myristica fragrans Houtt. Myristicaceae Nutmeg Seed 59 4
Myrtus communis L. Myrtaceae Myrtle Leaf 20 7
Ocimum basilicum L. Lamiaceae Basil Leaf 14 5
Origanum majorana L. Lamiaceae Marjoram Leaf 10 1
Origanum vulgare L. Lamiaceae Oregano Leaf 9 4
Pelargonium graveolens
L’Hér. Geraniaceae Geranium Leaf 9 3
Pimpinella anisum L. Apiaceae Aniseed Fruit 27 5
Pinus mugo Turra Pinaceae Pine needle Leaf/Twig no activity -
Pinus sylvestris L. Pinaceae Pine sylvestris Leaf/Twig no activity -
Piper nigrum L. Piperaceae Black pepper Fruit no activity -
Pogostemon cablin
(Blanco) Benth. Lamiaceae Patchouli Leaf no activity -
Rosa × damascena Herrm. Rosaceae Rosa Flower no activity -
Salvia officinalis L. Lamiaceae Sage. Dalmatian Leaf 3 2
Salvia sclarea L. Lamiaceae Clary sage Leaf/Flower no activity -
Santalum album L. Santalaceae Sandalwood Wood no activity -
Syzygium aromaticum (L.)
Merr. and L.M.Perry Myrtaceae Clove oil Leaf/Buds no activity -
Thuja occidentalis L. Cupressaceae Cedar leaf Leaf 7 5
Thymus vulgaris L. Lamiaceae Thyme Leaf no activity -
Verbena officinalis L. Verbenaceae Vervain Leaf no activity -
Zingiber officinale Roscoe Zingiberaceae Ginger Rhizome no activity -
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Figure 1. Distribution of the investigated EOs across different botanical families.
2.1. Optimization of the In Vitro Enzymatic Test
EOs are poorly soluble in water, and, as in vitro enzymatic tests are carried out in an aqueous
buffer solution, the choice of the solvent to be used as a “bridge” to solubilize the EO i the mixture
test is the first asp ct t be optimized, while avoi ing inte ference with 1) enzymatic activity, 2) UV
absorption, and 3) pH variation. Three solv nts were tested as solubilizing solvents: ethyl acetate was
the nly e giving a cle solution when adding 50 µL of the EO solution, while methanol, nd ethanol
gave opalescent solutions. Absorbance at 540 nm and the pH variation of a 1 mL of buffer s lution
containing 50 µL of ethyl ace ate were measured to evaluate any possible interference. Absor ance
was f und to be very low (0.080 ± 0.0003, n = 5) and pH variation negligible (fr m 7.00 to 7.13) and
ethyl acetate as therefore selected as the “bridge” solvent. The required EO fi al concentration in the
reactio mixture was set at 0.670 mgmL−1 to match the half maximal inhibitory conc ntration (IC50) of
acarbose (0.601 ± 0.0673 mg mL−1). To minimize the a ount of ethyl acetate in the reaction mix u e,
thus avoiding partial inte ference with the enzymatic activity, 10 µL of a 200 mg mL−1 solutions
ethyl etate of each investigated EO were added to the enzymatic assay re tion mixture.
The high volatility of EO components is the second aspect to be considered. The parameters
to be defined in this respect are the headspace volume of the vial containing the reaction mixture,
and whether the biological test must be run in sealed vials. The experiments demonstrated that the
reaction must be carried out in closed vials to minimize the headspace and limit the loss of bioactive
volatile compounds in the headspace/environment (data not shown). A 4.0 mL vial was used for all of
the in vitro inhibition experiments as the total volume of the reaction mixture was 3.0 mL.
2.2. In Vitro α-Amylase Inhibition Test
The inhibitory activity against α-amylase of the EOs listed in Table 1 was tested in vitro
using a spectrophotometric assay (carried out in triplicate for each EOs) to evaluate their
antidiabetic/hypoglycemic properties. Acarbose was chosen as the α-amylase inhibitor positive
reference. The percentage α-amylase inhibition data are reported in Table 1. They were determined by
measuring the difference in absorbance as reported in the Experimental Section (see par. Section 3.2).
The most active EOs were Eucalyptus radiata, Myristica fragrans, and Laurus nobilis, which are
characterized by inhibition activities higher than, or very similar to, that of acarbose, 65%, 59%,
and 51%, respectively. Within the Lauraceae family, in addition to laurel EO, Cinnamomum camphora
(20%) showed interesting activity, although it was lower than that of acarbose. Similar considerations
can be made for other botanical families, with several species presenting interesting inhibition
activity, i.e., Myrtaceae (Corymbia citriodora 44%, Eucalyptus globulus 34%, Melaleuca viridiflora 28%,
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Myrtus communis 20%), Lamiaceae (Mentha arvensis 39%, Mentha x piperita 33%, and 40% for leaf and
leaf-twig EOs, respectively), and Compositae (Artemisia vulgaris 48% and Matricaria chamomilla 32%).
The percentage of inhibition of the most active EOs was confirmed by comparing the amounts
of maltose produced during the enzymatic reaction in absence and in presence of the possible
inhibitor. A calibration curve was built by plotting the optical density at 540 nm of solutions of
known concentration of maltose previously reacted with 3,5-dinitrosalicylic acid (DNSA) in function
of maltose concentration. Knowing the final absorbance at 540 nm, the effective amount of maltose
liberated during the enzymatic reaction was determined by interpolation from the regression line of
A 540nm on maltose concentration (y = −0.048 + 1.4x, r2 = 0.9985, 95% confidence interval for the
slope 1.3 < β < 1.5; SEb = 0.10, t0.005(2), 3 = 3.18). The results obtained using the two approaches
were compared, in particular for the three most active EOs, adopted as reference, i.e., laurel, nutmeg,
and eucalyptus (Table 2). Percentage inhibition values were found to match perfectly, as the variation
coefficient (% CV) was always below 0.8%.
Table 2. Comparison between the percentage of inhibition activity determined by absorbance differences











radiata 65 ± 3 1.53 ± 0.08 65 ± 4 1.54 ± 0.11 0.080
Myristica
fragrans 59 ± 4 1.70 ± 0.13 58 ± 5 1.71 ± 0.17 0.780
Laurus
nobilis 51 ± 8 1.98 ± 0.32 51 ± 5 1.98 ± 0.19 0.120
Acarbose 56 ± 6 1.80 ± 0.20 55 ± 6 1.80 ± 0.22 0.020
1 = Half-maximal inhibitory concentration, 2 = Coefficient of variation.
Twenty-three EOs belonging to different botanical families were found to be inactive in inhibiting
α-amylase at the tested concentration under the applied experimental conditions: Cinnamomum
zeylanicum and Cinnamomum cassia, several species belonging to Lamiaceae (i.e., lemon balm, clary
sage, thyme, and patchouli), fennel and clove, among others.
2.3. Essential Oil Composition
All EOs, both active and inactive, were analyzed using gas chromatography, with flame ionization
(FID) and mass spectrometry (MS) detectors, to characterize their composition and evaluate the relative
percentage abundance of hydrocarbons and oxygenated compounds for correlation with the α-amylase
inhibition activity. Table 3 reports the percentage of hydrocarbons and oxygenated compounds for
each active EO, together with the most abundant compounds that characterize their composition.
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Table 3. List of the most abundant specialized metabolites and hydrocarbon and oxygenated compounds
percentage composition of those EOs displaying α-amylase inhibitory activity. (The complete chemical
composition of each investigated EO is reported in Table S1 of Supplementary Material). Bold




List of the Most Abundant
Components
Artemisia vulgaris L 9.0 91.0
α-Thujone (47.4), Camphor (30.0),
β-Thujone (7.80), Sabinene (3.90),
Camphene (3.70)
Carum carvi L. 37.8 62.2





camphora (L.) J.Presl 54.8 45.2
1,8-Cineole (44.1), Limonene (17.4),
p-Cymene (14.6), α-Terpinene (9.60),
β-Pinene (7.60)
Citrus × aurantium
L. (neroli) 97.5 2.5
Linalyl acetate (41.4), Linalool (28.5),




Limonene (90.2), β -Myrcene (3.70),
Linalyl acetate (1.60), α-Pinene (0.900),
Sabinene (0.500)
Citrus × aurantium
L. (Petit grain) 7.4 92.6
Linalyl acetate (56.8), Linalool (24.4),
α-Terpineol (5.60), Geranyl acetate
(3.40), Neryl acetate (1.80)
Citrus bergamia
Risso et Poiteau 52.0 48.0
Linalyl acetate (34.1), Limonene (32.3),




Limonene (71.9), β-Pinene (11.6),
γ -Terpinene (7.90), α-Pinene (1.50),
β-Myrcene (1.50)
Citrus medica L. 72.5 27.5
Limonene (54.9), Linalyl acetate (14.5),
β-Pinene (9.10), Linalool (4.60),
Geranial (4.60)
Citrus nobilis Lour. 99.9 0.1
Limonene (75.6), γ -Terpinene (14.5),







(7.10), Citronellol (6.00), Citronellyl
acetate (1.50), 1,8-Cineole (0.800)
Cupressus
sempervirens L. 91.9 8.1
α-Pinene (46.7), ∆-3-Carene (25.3),
α-Terpinolene (4.20), Limonene (4.00),
α-Terpinyl acetate (3.30)
Cymbopogon nardus
(L.) Rendle 11.6 88.4
Citronellal (37.9), Geraniol (19.5),






Geranial (38.2), Neral (32.5), Geraniol






α-Terpinyl acetate (43.8), 1,8-Cineole
(34.7), Linalyl acetate (6.00), Linalool
(2.70), Limonene (2.20)









1,8-Cineole (82.1), Limonene (6.80),
γ-Terpinene (3.30), p-Cymene (3.10),
α-Pinene (2.20)
Eucalyptus radiata
A.Cunn. ex DC. 14.6 84.9
1,8-Cineole (75.1), α-Terpineol (7.6),









α-Pinene (35.9), β -Myrcene (14.2),




β -Himachalene (50.8), α
-Himalachene (16.0), γ-Himalachene
(10.0), δ-Cadinene (2.50), α
-Chamigrene (2.00)
Laurus nobilis L. 20.5 79.5
1,8-Cineole (65.4), α-Terpinyl acetate






Linalyl acetate (35.6), Linalool (27.1),
Camphor (9.40), 1,8-Cineole (7.60),
Borneol (3.40)
Lavandula
angustifolia Mill. 13.8 86.2
Linalyl acetate (34.7), Linalool (27.9),
trans-β-Caryophyllene (4.20),




Geranial (42.4), Neral (34.6),
Limonene (12.6), Sabinene (1.90),
α-Pinene (1.20)
Matricaria
chamomilla L. 36.0 64.0
α-Bisabolol oxide A (47.0),
trans-β-Farnesene (24.0), α-Bisabolol










Sol. ex Gaertn. 23.4 76.6
1,8-Cineole (64.9), Limonene (9.50),
α-Pinene (6.20), α-Terpineol (4.20),
Viridiflorol (2.40)
Mentha × piperita L.
(leaf) 1.1 98.9
Menthol (48.2), Menthone (24.9),
Isomenthone (13.3), Menthyl acetate
(6.40), Neomenthol (2.00)
Mentha × piperita L.
(Leaf/Twig) 0.9 99.1
Menthol (52.0), Menthone (23.0),
Isomenthone (10.0), Menthyl acetate
(4.60), Neomenthol (4.26)
Mentha arvensis L. 6.6 93.4
Menthol (40.2), Menthone (19.5),
Isomenthone (8.00), Menthyl acetate
(7.40), Neomenthol (5.20)









Sabinene (27.0), α-Pinene (23.0),
β-Pinene (13.0), Limonene (10.0),
4-Terpineol (6.70)
Myrtus communis L. 56.1 43.9
Limonene (28.9), α-Pinene (15.1),
Mirtenyl acetate (13.6), Linalool
(13.50), Linalyl acetate (5.00)
Ocimum basilicum L 5.1 94.9






Linalool (34.0), 4-Terpineol (17.7),
γ-Terpinene (10.8), α-Terpinene (7.00),
Sabinene (5.80)
Origanum vulgare L. 28.8 71.2





graveolens L’Hér. 5.1 94.9
Citronellol (34.6), Geraniol (18.5),
Citronellyl formate (9.50), Linalool
(6.70), Isomenthone (5.10)
Pimpinella anisum L. 3.7 96.3
trans-Anethol (92.2), Limonene (2.1),
Estragole (1.70), Foeniculin (.0700),
Linalool (0.400)
Rosmarinus
officinalis L. 35.1 64.9
1,8-Cineole (43.3), Camphor (18.1),
α-Pinene (12.8), β-Pinene (9.50),
trans-β-Caryophyllene (5.90)
Salvia officinalis L. 32.2 67.8
α-Thujone (22.5), Camphor (18.5),








(9.10), Eugenyl acetate (7.10),
α-Humulene (1.10), Caryophyllene
oxide (0.300)
The total composition of all investigated EOs is reported in the Supplementary Material
(Tables S1–S6). Few EOs showed similar percentages for both hydrocarbon and oxygenated compounds:
Cinnamomum camphora, Citrus limon, Melaleuca alternifolia, Myrtus communis, and Origanum majorana.
Only eight EOs are characterized by high percentages (above 70%) of hydrocarbons: Citrus limon,
Citrus medica, Citrus nobilis, Citrus × aurantium, Cupressus sempervirens, Juniperus communis, Juniperus
virginiana, and Myristica fragrans. The others mostly consisted of oxygenated compounds (from 62.2%
of Carum carvi to 99.1% of Mentha × piperita).
2.4. Bio-Guided Assay Fractionation of Eucalyptus radiata and Myristica fragrans
Eucalyptus radiata and Myristica fragrans were selected from the most active EOs for further
bio-guided assay fractionation; the first is representative of a class of EOs with a composition that
is prevalently oxygenated monoterpenes, and the latter of a class of EOs that mainly consists of
terpenic hydrocarbons. While inhibiting α-amylase to nearly the same extent, Eucalyptus radiata and
Myristica fragrans EOs have significantly different chemical compositions, and their bioassay-oriented
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fractionation should thus provide good insight into the components that may be responsible for their
biological activity.
The pure oxygenated and hydrocarbon fractions of the investigated EOs were isolated using
automated flash chromatography and were individually subjected to α-amylase inhibitory assays.
The amount of the EO (960 mg) to be fractionated was selected so that a suitable amount of each
fraction could be recovered for the next biological testing.
Flash chromatography separations were carried out on pre-packed 50 µm silica gel cartridges
using a gradient of 0–20% ethyl-acetate in petroleum ether. All of the hydrocarbons eluted during
the isocratic step of the gradient with 100% petroleum ether, and the complete fractionation of the
pure material was completed within 20 minutes, regardless of the EO being treated. The yields of the
oxygenated and hydrocarbon fractions were 123.6 mg and 718.1 mg, respectively, for the Myristica
fragrans EO, and 744.7 mg and 82.4 mg, respectively, for Eucalyptus radiata. Each isolated fraction was
analyzed using GC-MS and GC-FID to assess the chemical composition of the fraction and its chemical
homogeneity. Figure 2 reports the GC-MS patterns of the total Eucalyptus radiata and Myristica fragrans
EO together with those of the corresponding hydrocarbon and oxygenated fractions. Table 4 reports
the composition of total Eucalyptus radiata and Myristica fragrans EOs, and of their hydrocarbon and
oxygenated fractions, as obtained by flash chromatography.Plants 2020, 9, x FOR PEER REVIEW 12 of 18 
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Table 4. Chemical composition of Eucalyptus radiata and Myristica fragrans EOs and that of their
respective hydrocarbon and oxygenated fractions.
# Compounds








1 α-Thujene 0.2 0.3 / / 0.7 /
2 α-Pinene 2.7 6.2 / 23.0 21.8 /
3 Sabinene 1.0 5.7 / 27.0 26.3 /
4 β-Pinene 0.6 4.2 / 13.0 20.4 /
5 β-Mircene 0.4 5.8 / 1.1 1.7 /
6 α-Phellandrene / / / 1.4 1.6 /
7 ∆-3-Carene / / / 0,4 0.6 /
8 α-Terpinene 4.4 / / 0.9 1.2 /
9 p-Cimene 0.6 11.3 / 0.7 2.1 /
10 Limonene 4.3 65.4 / 10.0 15.3 /
11 1,8-Cineole 75.1 / 69.8 1.8 / 5.0
12 trans-β-Ocimene tr 0.2 / 0.05 0.1 /
13 γ-Terpinene tr 0.1 / 4.9 6.6 /
14 α-Terpinolene tr 0.1 / 0.6 1.1 /
15 cis-SabineneHydrate / / / / / 0.7
16 trans-SabineneHydrate / / / / / 0.5
17 Linalool 0.3 / 0.7 0,2 / 1.6
18 Linalylpropionate 0.2 / 0.4 / / /
19 4-Terpineol 1.0 / 1.7 6.7 / 45.4
20 α-Terpineol 7.6 / 16.0 0.2 / 1.7
21 Eugenol / / / 0.5 / 4.5
22 Safrole / / / 0.7 / 1.1
23 Myristicin / / / 4.4 / 37.3
24 Neral 0.3 / 1.2 / / /
25 Geranial 0.4 / 1.6 / / /
26 α-Terpinylacetate 0.3 / 5.0 / / 1.8
27 trans-β-Caryophyllene/ 0.6 / / 0.2 /
The isolated oxygenated and hydrocarbon fractions for both EOs were tested separately for their
α-amylase inhibitory activity at the same concentration as the original EO. Only the oxygenated fraction
of Eucalyptus radiata EO inhibited α-amylase by 40%, while the hydrocarbon fraction was fully inactive.
The oxygenated fraction of Eucalyptus radiata mainly consists of 1,8-cineole (68.9%) and α-terpineol
(16.0%), which were found to be responsible for its α-amylase inhibitory activity. These compounds
inhibited α-amylase by 31 ± 2 (IC50 1.08 ± 0.0432 mg mL−1) and 33 ± 1% (IC50 1.01 ± 0.0221 mg mL−1),
respectively, when tested separately at a concentration of 0.670 mg mL−1. These values are quantitatively
close to that of acarbose (IC50 0.670 mg mL−1). Considering the relative percentage abundance of
1,8-cineole and α-terpineol in the oxygenated fraction of Eucalyptus radiata EO, and their respective
inhibitory activities, the bioactivity of Eucalyptus radiata oxygenated fractions seems to be the result
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of synergic interactions between the two identified bioactive compounds. The observed bioactivity
of 1,8-cineole agrees with the data available in the scientific literature [18,19]. However, a proper
comparison was not possible due to the absence of the positive control (i.e., acarbose) in the referenced
publications. The bioactivity of other tested EOs, namely Cinnamomum camphora, Eucalyptus globulus,
Hyssopus officinalis, Laurus nobilis, and Melaleuca viridiflora, can thus partially be ascribed to the presence
of 1,8-cineole, which is the major compound in all of the above mentioned EOs. However, linear
regression analyses (data not shown) did not reveal a significant positive linear relationship between
the amount of 1,8-cineole in an EO and the observed percentage of α-amylase inhibition. This is
probably because of combination effects with other EO components having an influence on 1,8-cineole
overall activity.
The hydrocarbon and oxygenated fractions of Myristica fragrans EO inhibited α-amylase by
11.1% and 15.0%, respectively. Unlike Eucalyptus radiata EO, the chemical composition of this EO
mainly consists of hydrocarbons, namely sabinene, α-pinene, β-pinene, and limonene, whose relative
percentage areas are 27.0%, 23.0%, 13.0%, and 10.0%, respectively, and that are present in the
corresponding isolated fraction in similar percentages (i.e., 26.3%, 21.8%, 20.4%, and 15.3%, respectively).
When tested as pure standards, at a concentration of 0.670 mg mL−1, sabinene and limonene were
inactive, while α- and β-pinene inhibited enzymatic activity by 32 ± 1% (IC50 1.05 ± 0.0252 mg mL−1)
and 29 ± 1% (IC50 1.17 ± 0.0233 mg mL−1), respectively. This result suggests that they are responsible
for the observed bioactivity of the hydrocarbon fraction, but that their contribution is only partial
compared to that of the whole EO. The oxygenated fraction mainly contains 4-terpineol which, similarly
to its structural isomer α-terpineol, inhibits α-amylase by 40 ± 2% (IC50 0.838 ± 0.0335 mg mL−1)
when tested individually at a concentration of 0.670 mg mL−1. Despite the evidence that has emerged
from these experiments, further studies into the mechanism of enzymatic inhibition of both Myristica
fragrans EO and its respective bioactive components are required to understand how they influence the
overall EO activity.
The results obtained from the bioassay-oriented fractionation of Myristica fragrans EO have
provided indications that allow us to, at least partially, understand the inhibition percentage results
of other screened EOs. In addition to Myristica fragrans, the investigated EOs that contain high
amounts of α and β-pinene are Cupressus sempervirens, Juniperus communis, Pinus mugo, and Pinus
sylvestris EOs. However, unexpectedly, only the Myristica fragrans and Cupressus sempervirens EOs
significantly inhibited α-amylase, while the others were inactive. In terms of chemical composition,
Myristica fragrans and Cupressus sempervirens EOs mainly differ from the others because they are
both free from trans-β-caryophyllene. Pearson’s correlation coefficient was thus measured to define
whether an association exists between the presence of trans-β-caryophyllene and biological activity.
The results suggest that the variables are indeed negatively related (r = −0.4583), and the correlation
was sufficiently high to warrant the rejection of the null hypothesis of zero correlation (t = −2.871,
df = 31, p-value = 0.007).
2.5. Data Precision
The precision of the in vitro α-amylase inhibition test was evaluated in terms of repeatability
(by repeating the enzymatic inhibition assay three times in the same day) and intermediate precision
(by repeating the enzymatic inhibition assay three times every four weeks over a period of six months).
Results were very satisfactory and never exceeded 8.1% for repeatability and 11.8% for intermediate
precision. Table 5 reports the percentage relative standard deviation (RSD%) for inhibition tests carried
out with acarbose (reference) and with laurel, eucalyptus, and nutmeg EOs. Similar precision values
were obtained for all the tested EOs.
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Table 5. Data precision expressed as percentage relative standard deviation (RSD%) for both repeatability
(n = 3) and intermediate precision (n = 6). * Values represent the average of three assays.
Repeatability (n = 3) Intermediate Precision





































* Values represent the average of three assays.
3. Materials and Methods
3.1. Reagents
Sixty-one EOs from different botanically authenticated species were supplied by Witt Italia
SpA. Mentha x piperita EO (leaves) was obtained from fresh leaves (provided by Dr. Franco Chialva,
Chialvamenta), and submitted to steam distillation. Table 1 reports the list of the EOs investigated,
including botanical and common name, botanical family, and the part of the plant from which the
EO was obtained. At least three different batches were considered for each EO. Pure standard
samples of 4-terpineol, α-terpineol, 1,8-cineole, α-pinene, β-pinene, sabinene and limonene (purity
> 98%) were purchased from Merck. The solvents were all HPLC-grade and obtained from Carlo
Erba. Phosphate saline buffer, α-amylase from Aspergillus oryzae, maltose, acarbose, potato starch,
and 3,5-dinitrosalicilic acid were also obtained from Merck.
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3.2. In Vitro α-Amylase Inhibition Test
The in vitro inhibition test adopted in this study was modified from that of Sigma-Aldrich [20].
Three different solvents (i.e., methanol, ethanol, and ethyl acetate) were tested to select the best one to
be used as “bridge” to solubilize the EOs into the test mixture. 15 mg mL−1 solutions of tangerine and
chamomile EOs were prepared for each investigated solvent. For each solution, 50 µL were added to
1 mL of buffer solution and UV absorption at 540 nm and pH variation were assessed. The enzyme
solution was prepared daily at a concentration of 33.3 µg/mL in a 0.02 M phosphate buffer (pH 6.9).
The starch solution (1% w/v) was obtained by stirring 1 g of potato starch in the same buffer at 90 ◦C
for 15 min. Then, 200 mL of the 3,5-dinitrosalicylic reagent was prepared as follows: first, 2.18 g of
3,5-dinitrosalicylic acid (DNSA) was dissolved in 40 mL NaOH 2 M and 100 mL of deionized water;
60 g of potassium citrate (Rochelle salt) was then added and the volume was made up to 200 mL with
deionized water; the solution was finally heated to 40 ◦C to dissolve the potassium citrate. The reactant
solution was stored in the dark and protected from CO2 [21]. A 200 mg mL−1 solution in ethyl acetate
was prepared and stored at 4 ◦C for each investigated EO, each standard sample, each isolated fraction,
and for acarbose.
Sample mixtures were prepared as follows: 10µL of each EO solution (corresponding to an absolute
amount of 2 mg) was added to 1 mL of enzyme solution (corresponding to 1 unit of α-amylase) and
pre-incubated for 5 min at 25 ◦C under constant stirring. Then, 1 mL of the starch solution was added
and incubated for 3 min at 25 ◦C. Finally, 1 mL of the DNSA solution was added and left to react
for 15 min at 90 ◦C. The mixture was then cooled and diluted with 9 mL of deionized water and the
absorbance was measured at 540 nm. The standard test containing the non-inhibited enzyme was
prepared as described above, with 10 µL of pure ethyl acetate instead of the EO solution. The final
concentration of EOs and acarbose in the reaction mixture was 0.67 mg mL−1 (i.e., 2 mg in terms of
absolute amount), which corresponds to IC50 for acarbose.
The α-amylase inhibition activity of each investigated EO was measured using two different
approaches. The first approach (Method A) relies on difference in absorbance and α-amylase inhibition
activity is measured by applying the following Equation (1):
% Inhibition =




(AStandard − AStandard blank)
× 100 (1)
where AStandard is the absorbance at 540 nm when the enzyme was not inhibited, AStandard blank is the
absorbance of the standard blank solution containing the same reagents as the standard mixture,
but with 1 mL of buffer instead of the enzyme, ASample is the absorbance at 540 nm in the presence of
the investigated inhibitor, and ASample blank is the absorbance of the sample blank solution prepared
with the same reagents as the sample mixture, including the 10 uL of the EO solution, but with 1 mL
of buffer instead of the enzyme. Each blank underwent the same steps as the corresponding sample.
A blank of each EO was performed to account for possible variations in absorbance due to differences
in EO chemical composition. Acarbose was used as the positive reference; positive reference inhibition
tests were carried out using 10 µL of acarbose solution at a concentration of 200 mgmL−1 in ethyl
acetate (corresponding to an absolute amount of 2 mg).
The second approach (Method B) measures amylase inhibition activity considering the differences
in the amount of maltose generated by α-amylase activity via the reduction of 3,5-dinitrosalicylic acid
to 3-amino-5-nitrosalicylic acid, by applying the following Formula (2):




where Cmaltose sample is the concentration of maltose produced by α-amylase in the presence of EO or
acarbose, and Cmaltose Standard is the concentration of maltose produced by the non-inhibited α-amylase.
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3.3. Maltose Calibration Curve
Maltose solutions were prepared in 0.02 M phosphate buffer (pH 6.9) at seven different
concentrations: 1.0, 0.75, 0.50, 0.25, 0.20, 0.15, and 0.10 mg mL−1. Then, 1.0 mL of each solution was
mixed with 1.0 mL of buffer solution and 1 mL of the DNSA solution and the mixture was left to react
for 15 min at 90 ◦C. Once the reaction was finished, the mixture was cooled and diluted with 9 mL of
deionized water and the absorbance was read at 540 nm. The maltose calibration curve was built by
plotting the absorbance at 540 nm as a function of maltose concentration (mg mL−1).
3.4. Flash Column Chromatography
EO fractionation was carried out on a flash column chromatography system PuriFlash 450 by
Sepachrom, equipped with both UV and Evaporative Light Scattering (ELSD) detectors. Stationary
phase: Sepachrom silica Daily 50 µm; mobile phase: petrolether (A) and ethyl acetate (B), flow 25 mL
min−1. Linear gradient elution was adopted from 100% of A to 80% of A and 20% of B in 20 min.
3.5. Analysis Conditions
GC-MS analyses were carried out using a Gerstel MPS-2 multipurpose sampler installed on
a Shimadzu 2010 GC unit coupled to a Shimadzu QP2010 Mass spectrometer. GC conditions: injector
temperature: 280 ◦C, injection mode: split, ratio: 1/20; carrier gas: helium, flow rate: 1 mL min−1;
column: Mega SE 52 (95% polydimethylsiloxane, 5% phenyl) 25 m × 0.25 mm dc × 0.25 µm df,
from MEGA. Temperature program: from 50 ◦C (1 min) to 250 ◦C (5 min) at 3 ◦C min−1. MSD
conditions: MS operated in EI mode (70 eV), scan range: 35 to 350 amu; dwell time 40 ms, ion source
temperature: 230 ◦C; quadrupole temperature: 150 ◦C; transfer line temperature: 280 ◦C. EO markers
were identified by comparing both their linear retention indices (LRIs), calculated versus a C9-C25
hydrocarbon mixture, and their mass spectra against those of authentic samples, or from commercially
available mass spectral libraries (Adams, 2007).
GC-FID analyses were carried out on the previously-described Shimadzu 2010 GC unit. GC
conditions: injector temperature: 280 ◦C, injection mode: split, ratio: 1/20; carrier gas: hydrogen,
flow rate: 1 mL min−1; column: Mega SE 52 (95% polydimethylsiloxane, 5% phenyl) 25 m × 0.25 mm
dc × 0.25 µm df, from MEGA. Temperature program: from 50 ◦C (1 min) to 250 ◦C (5 min) at 3 ◦C
min−1. Relative percentage composition of the analyzed EOs was determined using GC-FID peak
areas with response factors [22,23].
4. Conclusions
This study explores the α-amylase inhibition ability of 62 EOs of different composition and
belonging to different plant families. Under the applied experimental conditions, three EOs showed
high inhibitory capacity (Eucalyptus radiata, Laurus nobilis, and Myristica fragrans) that was comparable
or slightly higher than that of acarbose, which was chosen as the positive control. The results
showed that the EO components seem to act synergistically, as the total EO percentage inhibition
activity is higher than those of both the combined isolated fractions and pure compounds. Moreover,
an interesting number of both hydrocarbon and oxygenated compounds. were characterized as
good α-amylase inhibitors, with percentage inhibitions of about 30% (i.e., 1,8-cineole, 4-terpineol,
α-terpineol α-pinene, and β-pinene). These results demonstrate that EO oils are a promising source of
potential α-amylase inhibitors.
Supplementary Materials: The following are available online at http://www.mdpi.com/2223-7747/9/9/1242/s1.
Tables S1–S6: total chemical composition (expressed as relative percentage area of each identified compound of
the 62 investigated essential oils).
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